Presentation TCT 2023 TCT 307: Percutaneous Coronary Intervention Outcomes Stratified by Body Mass Index. Are Obesity Classes Created Equally? A Retrospective Population-Based Study Presenter: Carlos Gaibor October 26, 2023
Presentation TCT 2023 TCT 298: Bariatric Arterial Embolization: a Mini-invasive Procedure for Treating Obesity Presenter: Gustavo Samaja October 26, 2023
Presentation TCT 2023 TCT 13: Metabolic Syndrome, a new predictor of coronary artery calcification burden: An Optical Coherence Tomography Study Presenter: Francesca Maria Di Muro October 26, 2023
Presentation TCT 2023 TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial Presenter: Minju Han October 25, 2023
News Daily News Pooled Cohort Equations Work in Real-world Patients, Even Outliers Yael L. Maxwell October 12, 2023
News Conference News HFSA 2023 Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis Todd Neale October 11, 2023
News Daily News Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study L.A. McKeown October 10, 2023
News Daily News Positive Phase III Results Bring Excitement for Novel PET Imaging Tracer Todd Neale October 10, 2023
News Daily News Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs Caitlin E. Cox October 06, 2023
News Daily News To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke Todd Neale October 03, 2023
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Daily News GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters Shelley Wood September 28, 2023
News Daily News Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis L.A. McKeown September 25, 2023
News Daily News Slight Declines in Kidney Function Portend CV Trouble for Young Adults Todd Neale September 18, 2023
News Daily News European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba Michael O'Riordan September 15, 2023
News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023
News Daily News Subclinical HFpEF Common in Patients Undergoing AF Ablation Todd Neale September 08, 2023
News Daily News Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts Michael O'Riordan September 08, 2023
News Conference News ESC 2023 STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function Shelley Wood August 25, 2023
News Opinion Editor's Corner ESC 2023 What’s Going to Be Hot at ESC 2023? Shelley Wood August 15, 2023